Literature DB >> 121949

Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent delivery.

E A Neuwelt, E P Frenkel, J T Diehl, K R Maravilla, L H Vu, W K Clark, S I Rapoport, P A Barnett, S A Hill, S E Lewis, A L Ehle, C W Beyer, R J Moore.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 121949

Source DB:  PubMed          Journal:  Trans Am Neurol Assoc        ISSN： 0065-9479


× No keyword cloud information.
  15 in total

1.  The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain.

Authors:  Sadhana Jackson; Nicole M Anders; Antonella Mangraviti; Teresia M Wanjiku; Eric W Sankey; Ann Liu; Henry Brem; Betty Tyler; Michelle A Rudek; Stuart A Grossman
Journal:  J Neurooncol       Date:  2015-12-01       Impact factor: 4.130

2.  Adenosine receptor signaling modulates permeability of the blood-brain barrier.

Authors:  Aaron J Carman; Jeffrey H Mills; Antje Krenz; Do-Geun Kim; Margaret S Bynoe
Journal:  J Neurosci       Date:  2011-09-14       Impact factor: 6.167

Review 3.  Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going.

Authors:  Randy S D'Amico; Deepak Khatri; Noah Reichman; Nitesh V Patel; Tamika Wong; Sherese R Fralin; Mona Li; Jason A Ellis; Rafael Ortiz; David J Langer; John A Boockvar
Journal:  J Neurooncol       Date:  2020-02-19       Impact factor: 4.130

4.  Real-time MRI guidance for intra-arterial drug delivery in a patient with a brain tumor: technical note.

Authors:  Michal Zawadzki; Jerzy Walecki; Boguslaw Kostkiewicz; Kacper Kostyra; Monica Smith Pearl; Meiyappan Solaiyappan; Piotr Walczak; Miroslaw Janowski
Journal:  BMJ Case Rep       Date:  2019-01-24

Review 5.  Using manganese-enhanced MRI to understand BOLD.

Authors:  Afonso C Silva
Journal:  Neuroimage       Date:  2012-01-08       Impact factor: 6.556

6.  A Distinct Advantage to Intraarterial Delivery of 89Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood-Brain Barrier.

Authors:  Wojciech G Lesniak; Chengyan Chu; Anna Jablonska; Yong Du; Martin G Pomper; Piotr Walczak; Miroslaw Janowski
Journal:  J Nucl Med       Date:  2018-10-12       Impact factor: 10.057

7.  Feasibility of using hyperosmolar mannitol as a liquid tumor embolization agent.

Authors:  Lei Feng; Beverly A Kienitz; Carolyn Matsumoto; Jeffrey Bruce; Michael Sisti; Hoang Duong; John Pile-Spellman
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

8.  Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy.

Authors:  Shailendra Joshi; Johann R N Cooke; Jason A Ellis; Charles W Emala; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2017-09-05       Impact factor: 4.130

9.  Acute dimethyl sulphoxide therapy in experimental brain oedema, effect of dose and concentration on brain water and electrolyte content.

Authors:  J Tsuruda; H E James; R Werner; P E Camp; G Rasmussen
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

Review 10.  Manganese-enhanced MRI: an exceptional tool in translational neuroimaging.

Authors:  Afonso C Silva; Nicholas A Bock
Journal:  Schizophr Bull       Date:  2008-06-11       Impact factor: 9.306
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.